{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:25:17Z","timestamp":1791033917326,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T00:00:00Z","timestamp":1124150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T00:00:00Z","timestamp":1124150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1038\/sj.tpj.6500327","type":"journal-article","created":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T07:29:26Z","timestamp":1124177366000},"page":"324-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Clinical response to morphine in cancer patients and genetic variation in candidate genes"],"prefix":"10.1038","volume":"5","author":[{"given":"J R","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"Joel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Goller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A U","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,8,16]]},"reference":[{"key":"BF6500327_CR1","unstructured":"World Health Organisation. Cancer Pain Relief, 2nd edn. World Health Organisation: Geneva, Switzerland, 1996."},{"key":"BF6500327_CR2","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","volume":"19","author":"N Cherny","year":"2001","unstructured":"Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001; 19: 2542\u20132554.","journal-title":"J Clin Oncol"},{"key":"BF6500327_CR3","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0","volume":"76","author":"NJ Cherny","year":"1995","unstructured":"Cherny NJ, Chang V, Frager G, Ingham JM, Tiseo PJ, Popp B et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 1995; 76: 1283\u20131293.","journal-title":"Cancer"},{"key":"BF6500327_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1191\/0269216304pm856oa","volume":"18","author":"J Riley","year":"2004","unstructured":"Riley J, Ross JR, Rutter D, Shah S, Gwilliam B, Wells AU et al. A retrospective study of the association between haematological and biochemical parameters and morphine intolerance in patients with cancer pain. Palliat Med 2004; 18: 19\u201324.","journal-title":"Palliat Med"},{"key":"BF6500327_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00008571-199512000-00001","volume":"5","author":"SH Sindrup","year":"1995","unstructured":"Sindrup SH, Brosen K . The pharmacogenetics of codeine hypoalgesia. Pharmacogenetics 1995; 5: 335\u2013346.","journal-title":"Pharmacogenetics"},{"key":"BF6500327_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1191\/0269216303pm658oa","volume":"17","author":"C Quigley","year":"2003","unstructured":"Quigley C, Joel S, Patel N, Baksh A, Slevin M . Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain. Palliat Med 2003; 17: 185\u2013190.","journal-title":"Palliat Med"},{"key":"BF6500327_CR7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1191\/0269216303pm835oa","volume":"17","author":"P Klepstad","year":"2003","unstructured":"Klepstad P, Borchgrevink PC, Dale O, Zahlsen K, Aamo T, Fayers P et al. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients. Palliat Med 2003; 17: 679\u2013687.","journal-title":"Palliat Med"},{"key":"BF6500327_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0009-9236(03)00053-5","volume":"73","author":"MB Sawyer","year":"2003","unstructured":"Sawyer MB, Innocenti F, Das S, Cheng C, Ramirez J, Pantle-Fisher FH et al. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin Pharmacol Ther 2003; 73: 566\u2013574.","journal-title":"Clin Pharmacol Ther"},{"key":"BF6500327_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.tpj.6500139","volume":"3","author":"M Holthe","year":"2003","unstructured":"Holthe M, Rakvag TN, Klepstad P, Idle JR, Kaasa S, Krokan HE et al. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenom J 2003; 3: 17\u201326.","journal-title":"Pharmacogenom J"},{"key":"BF6500327_CR10","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/S0140-6736(99)03528-X","volume":"353","author":"H McQuay","year":"1999","unstructured":"McQuay H . Opioids in pain management. Lancet 1999; 353: 2229\u20132232.","journal-title":"Lancet"},{"key":"BF6500327_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0163-7258(95)02011-X","volume":"68","author":"M Satoh","year":"1995","unstructured":"Satoh M, Minami M . Molecular pharmacology of the opioid receptors. Pharmacol Therap 1995; 68: 343\u2013364.","journal-title":"Pharmacol Therap"},{"key":"BF6500327_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1440-1681.1999.03049.x","volume":"26","author":"M Connor","year":"1999","unstructured":"Connor M, MacDonald JC . Opioid receptor signalling mechanisms. Clin Exp Pharmacol Physiol 1999; 26: 493\u2013499.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF6500327_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1213\/00000539-199301000-00031","volume":"76","author":"C Stein","year":"1993","unstructured":"Stein C . Peripheral mechanisms of opioid analgesia. Anesth Analg 1993; 76: 182\u2013191.","journal-title":"Anesth Analg"},{"key":"BF6500327_CR14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/CDLI.7.5.719-723.2000","volume":"7","author":"JM Bidlack","year":"2000","unstructured":"Bidlack JM . Detection and function of opioid receptors on cells from the immune system [Review] [67 refs]. Clin Diagn Lab Immunol 2000; 7: 719\u2013723.","journal-title":"Clin Diagn Lab Immunol"},{"key":"BF6500327_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/00001503-199910000-00020","volume":"12","author":"S Clarke","year":"1999","unstructured":"Clarke S, Kitchen I . Opioid analgesia: new information from gene knockout studies. Curr Opin Anaesthesiol 1999; 12: 609\u2013614.","journal-title":"Curr Opin Anaesthesiol"},{"key":"BF6500327_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/1381612043452992","volume":"10","author":"HT Ravert","year":"2004","unstructured":"Ravert HT, Bencherif B, Madar I, Frost JJ . PET imaging of opioid receptors in pain: progress and new directions. Curr Pharm Des 2004; 10: 759\u2013768.","journal-title":"Curr Pharm Des"},{"key":"BF6500327_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1176\/ajp.156.6.842","volume":"156","author":"JK Zubieta","year":"1999","unstructured":"Zubieta JK, Dannals RF, Frost JJ . Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry 1999; 156: 842\u2013848.","journal-title":"Am J Psychiatry"},{"key":"BF6500327_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s001090050246","volume":"76","author":"B Wendel","year":"1998","unstructured":"Wendel B, Hoehe MR . The human mu opioid receptor gene: 5\u2032 regulatory and intronic sequences. J Mol Med 1998; 76: 525\u2013532.","journal-title":"J Mol Med"},{"key":"BF6500327_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1124\/mol.61.4.800","volume":"61","author":"C Borner","year":"2002","unstructured":"Borner C, Hollt V, Kraus J . Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene. Mol Pharmacol 2002; 61: 800\u2013805.","journal-title":"Mol Pharmacol"},{"key":"BF6500327_CR20","doi-asserted-by":"publisher","first-page":"43901","DOI":"10.1074\/jbc.M107543200","volume":"276","author":"J Kraus","year":"2001","unstructured":"Kraus J, Borner C, Giannini E, Hickfang K, Braun H, Mayer P et al. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 2001; 276: 43901\u201343908.","journal-title":"J Biol Chem"},{"key":"BF6500327_CR21","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1073\/pnas.90.21.10230","volume":"90","author":"JB Wang","year":"1993","unstructured":"Wang JB, Imai Y, Eppler CM, Gregor P, Spivak CE, Uhl GR . Mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci USA 1993; 90: 10230\u201310234.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6500327_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0169-328X(99)00332-0","volume":"76","author":"K Chaturvedi","year":"2000","unstructured":"Chaturvedi K, Shahrestanifar M, Howells RD . \u03bc Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity. Mol Brain Res 2000; 76: 64\u201372.","journal-title":"Mol Brain Res"},{"key":"BF6500327_CR23","doi-asserted-by":"crossref","first-page":"20548","DOI":"10.1016\/S0021-9258(17)32028-8","volume":"269","author":"CK Surratt","year":"1994","unstructured":"Surratt CK, Johnson PS, Moriwaki A, Seidleck BK, Blaschak CJ, Wang JB et al. Mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J Biol Chem 1994; 269: 20548\u201320553.","journal-title":"J Biol Chem"},{"key":"BF6500327_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/sj.bjp.0704263","volume":"134","author":"J Pil","year":"2001","unstructured":"Pil J, Tytgat J . The role of the hydrophilic Asn230 residue of the mu-opioid receptor in the potency of various opioid agonists. Br J Pharmacol 2001; 134: 496\u2013506.","journal-title":"Br J Pharmacol"},{"key":"BF6500327_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1124\/mol.53.3.377","volume":"53","author":"DE Keith","year":"1998","unstructured":"Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV et al. mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 1998; 53: 377\u2013384.","journal-title":"Mol Pharmacol"},{"key":"BF6500327_CR26","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","volume":"286","author":"LM Bohn","year":"1999","unstructured":"Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT . Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 1999; 286: 2495\u20132498.","journal-title":"Science"},{"key":"BF6500327_CR27","doi-asserted-by":"crossref","unstructured":"Riley J, Ross JR, Rutter D, Wells AU, Goller K, DuBois R, Welsh KI . No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid. Support Care Cancer 2005 June 11 2005; Epub ahead of print.","DOI":"10.1007\/s00520-005-0843-2"},{"key":"BF6500327_CR28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5694\/j.1326-5377.1999.tb126885.x","volume":"170","author":"MA Ashby","year":"1999","unstructured":"Ashby MA, Martin P, Jackson KA . Opioid substitution to reduce adverse effects in cancer pain management. Med J Aust 1999; 170: 68\u201371.","journal-title":"Med J Aust"},{"key":"BF6500327_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s005200050259","volume":"7","author":"B Gagnon","year":"1999","unstructured":"Gagnon B, Bielech M, Watanabe S, Walker P, Hanson J, Bruera E . The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Support Care Cancer 1999; 7: 265\u2013270.","journal-title":"Support Care Cancer"},{"key":"BF6500327_CR30","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1523\/JNEUROSCI.22-23-10494.2002","volume":"22","author":"LM Bohn","year":"2002","unstructured":"Bohn LM, Lefkowitz RJ, Caron MG . Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci 2002; 22: 10494\u201310500.","journal-title":"J Neurosci"},{"key":"BF6500327_CR31","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","volume":"95","author":"C Bond","year":"1998","unstructured":"Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998; 95: 9608\u20139613.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6500327_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/(SICI)1096-8628(19991015)88:5<458::AID-AJMG3>3.0.CO;2-S","volume":"88","author":"T Town","year":"1999","unstructured":"Town T, Abdullah L, Crawford F, Schinka J, Ordorica PI, Francis E et al. Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet 1999; 88: 458\u2013461.","journal-title":"Am J Med Genet"},{"key":"BF6500327_CR33","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/sj.mp.4000331","volume":"2","author":"AW Bergen","year":"1997","unstructured":"Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M et al. Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry 1997; 2: 490\u2013494.","journal-title":"Mol Psychiatry"},{"key":"BF6500327_CR34","first-page":"2108","volume":"22","author":"T Sander","year":"1998","unstructured":"Sander T, Gscheidel N, Wendel B, Samochowiec J, Smolka M, Rommelspacher H et al. Human \u03bc opioid receptor variation and alcohol dependence. Alcohol Clin Exp Res 1998; 22: 2108\u20132110.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF6500327_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/13556210050003775","volume":"5","author":"T Li","year":"2000","unstructured":"Li T, Liu X, Zhu ZH, Zhao J, Hu X, Sham PC et al. Association analysis of polymorphisms in the \u03bc opioid gene and heroin abuse in Chinese subjects. Addict Biol 2000; 5: 181\u2013186.","journal-title":"Addict Biol"},{"key":"BF6500327_CR36","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/00000542-200210000-00011","volume":"97","author":"J Lotsch","year":"2002","unstructured":"Lotsch J, Zimmermann M, Darimont J, Marx C, Dudziak R, Skarke C et al. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity? Anesthesiology 2002; 97: 814\u2013819.","journal-title":"Anesthesiology"},{"key":"BF6500327_CR37","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1124\/dmd.31.5.677","volume":"31","author":"T Hirota","year":"2003","unstructured":"Hirota T, Ieiri I, Takane H, Sano H, Kawamoto K, Aono H et al. Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy. Drug Metab Dispos 2003; 31: 677\u2013680.","journal-title":"Drug Metab Dispos"},{"key":"BF6500327_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00008571-200201000-00002","volume":"12","author":"J Lotsch","year":"2002","unstructured":"Lotsch J, Skarke C, Grosch S, Darimont J, Schmidt H, Geisslinger G . The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine. Pharmacogenetics 2002; 12: 3\u20139.","journal-title":"Pharmacogenetics"},{"key":"BF6500327_CR39","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1093\/hmg\/9.19.2895","volume":"9","author":"MR Hoehe","year":"2000","unstructured":"Hoehe MR, Kopke K, Wendel B, Rohde K, Flachmeier C, Kidd KK et al. Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet 2000; 9: 2895\u20132908.","journal-title":"Hum Mol Genet"},{"key":"BF6500327_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/13556219772598","volume":"2","author":"WH Berrettini","year":"1997","unstructured":"Berrettini WH, Hoehe MR, Ferraro TN, DeMaria PA, Gottheil E . Human \u03bc opioid receptor gene polymorphisms and vulnerability to substance abuse. Addict Biol 1997; 2: 303\u2013308.","journal-title":"Addict Biol"},{"key":"BF6500327_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-2999(00)00819-0","volume":"410","author":"KS LaForge","year":"2000","unstructured":"LaForge KS, Yuferov V, Kreek MJ . Opioid receptor and peptide gene polymorphisms: potential implications for addictions [Erratum appears in Eur J Pharmacol 2001 Aug 24; 426(1\u20132): 145]. Eur J Pharmacol 2000; 410: 249\u2013268.","journal-title":"Eur J Pharmacol"},{"key":"BF6500327_CR42","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes SS, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.","journal-title":"Nucleic Acids Res"},{"key":"BF6500327_CR43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0378-4347(00)83176-X","volume":"430","author":"S Joel","year":"1988","unstructured":"Joel S, Osborne R, Slevin M . An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites. Chromatography 1988; 430: 394\u2013399.","journal-title":"Chromatography"},{"key":"BF6500327_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/B:BRAT.0000019185.30489.ad","volume":"16","author":"R Dowman","year":"2004","unstructured":"Dowman R . Topographic analysis of painful laser and sural nerve electrical evoked potentials. Brain Topogr 2004; 16: 169\u2013179.","journal-title":"Brain Topogr"},{"key":"BF6500327_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/hmg\/ddg066","volume":"12","author":"T Ahmad","year":"2003","unstructured":"Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet 2003; 12: 647\u2013656.","journal-title":"Hum Mol Genet"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/6500327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6500327","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6500327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T11:00:35Z","timestamp":1647946835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6500327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,16]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10,1]]}},"alternative-id":["BF6500327"],"URL":"https:\/\/doi.org\/10.1038\/sj.tpj.6500327","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,16]]},"assertion":[{"value":"5 January 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}